Da Ren

Dr. Da Ren is the founder and CEO of BioTherapeutics Solutions, an analytical solution provider for the biopharmaceutical industry. Prior to starting BioTherapeutics Solutions, he was a Scientific Director at Amgen in charge of analytical platforms and global strategy of the Multi-Attribute Method (MAM). In 2015, he led the first-in-industry implementation of MAM in the cGMP environment. Since then, MAM has been accepted by over 30 regulatory agencies around the world. Da is on the advisory board of several companies and serves multiple roles in industry-wide organizations including USP, CASSS, ASMS, and MAM Consortium. Prior to Amgen, Da was a Senior Applications Chemist at Waters Corporation. He received his Ph.D. in Analytical Chemistry from the University of Akron in 2002.